CLINICAL_TRIALS
trial_result
· 2013-12-03
Clinical Trial Update: Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy [Phase 3]
Summary
A Phase 3 clinical trial evaluating lamotrigine for newly diagnosed epilepsy has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2013-12-03